DXCM News and Press, DexCom Inc. From 05/17/22

In its recent 13-F filing, Coatue Management indicated a fund value total of $13.7B wherein it acquired new stakes in Lucid (LCID) with 2.97M shares, Zillow (ZG) with 2.36M shares, Docusign (DOCU) with 1.46M shares, AMC Entertainment (AMC) with 5.19M shares and Beyond Meat (BYND) with 5M shar...

BofA strategists have names for investors looking to put cash back to work after the 2022 selloff. The equity strategy teams highlighted two Buy the Dip screens this week. Beaten-down tech "Tech and Growth stocks have been the biggest laggards YTD amid a hawkish Fed," strategist Savita Subram...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. The market was very weak in the quarter for a plethora of reasons. The Fed is in a tough position, as it needs to sig...

Tandem Diabetes Care (NASDAQ:TNDM) is trading sharply lower in the morning hours Thursday after the insulin pump maker posted mixed 1Q 2022 financials and at least four Wall Street analysts trimmed their price targets on the stock. Rival makers of insulin pumps, Insulet (PODD) and Medtronic (...

IYH gained 12% during 7 weeks from February 22, and then fell by 9% in the next 3 weeks. IYH posted strong price returns over the medium and long term, but generated 1% yield. Biotechnology and Life Sciences Tools & Services companies historically had cyclical price movements,...

DexCom reported its Q1'22 earnings on Thursday - $629m of revenues, up 25% year-on-year, but net income of $41m, down 250 basis points. DexCom is a high growth startup transitioning into a market incumbent in a lucrative market and management deserves huge praise for its achievements....

The following slide deck was published by DexCom, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: DexCom, Inc. 2022 Q1 - Results - Earnings Call Presentation

If you were to strictly look at earnings multiples, you could easily miss a top growth stock like DexCom (NASDAQ: DXCM) . Initially, value investors might scoff at the whopping 200+ times earnings that it trades at right now. But that wouldn't tell you the whole story. The reali...

Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q1 2022 Earnings Call Apr 28, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom (DXCM) Q1 2022 Earnings Call Transcript

DexCom, Inc. (DXCM) Q1 2022 Earnings Conference Call April 28, 2022 17:30 ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and Chief Executive Officer Jereme Sylvain - Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Dani...